AYTU Aytu BioPharma, Inc.

NASDAQ

$1.83

Aytu BioPharma, Inc. (AYTU) is expected to report earnings on November 19, 2026, after the market close. The consensus earnings estimate is a loss of $0.10 per share, and the stock has had a Post-Earnings Announcement Drift (PEAD) of -21.8% since its last earnings release on September 22, 2026.

Aytu BioPharma Beat Consensus Estimates

Tuesday, September 22, 2026 · 4:05 PM ET

1st Quarter, Sep 2026

Thursday · 4:05 PM ET

Earnings Whisper

-

vs ($0.10)

Rev est $14.5M

Volatility

Enter your expectations below to reveal the current volatility.

Trend Analysis

Expectation

Earnings

Price action

Signals

Score

Sentiment

Grade

Life Cycle

Call Analysis

Earnings-AVWAP $2.07

Sign in or subscribe to unlock sentiment, short interest, and technical indicators.

About Aytu BioPharma, Inc.

Aytu BioPharma is a specialty pharmaceutical company with a growing commercial portfolio of prescription therapeutics and consumer health products.

Sector

Healthcare

Industry

Biotechnology

Charts powered in part by Lightweight Charts™ by TradingView.